BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.535
+0.105 (4.32%)
Sep 23, 2026, 1:59 PM EDT - Market open
BioLineRx Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 0.29 | 0.48 | 0.19 | 0.43 | 0.3 | 0.26 | 11.75 | 4.94 | 5.39 | 6.86 | 4.8 | - | - | - | - | - | - | - | - | - | |
Revenue Growth (YoY) | -3.29% | 87.06% | -98.35% | -91.36% | -94.36% | -96.28% | 144.77% | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue | 0.06 | 0.1 | 0.04 | 0.08 | 0.07 | 0.03 | 6.09 | 0.82 | 0.9 | 1.46 | 3.69 | - | - | - | - | - | - | - | - | - |
Gross Profit | 0.24 | 0.38 | 0.15 | 0.34 | 0.23 | 0.22 | 5.66 | 4.12 | 4.5 | 5.4 | 1.11 | - | - | - | - | - | - | - | - | - |
Selling, General & Admin | 0.87 | 0.86 | 1.12 | 0.83 | 0.21 | 0.99 | 6.97 | 6.94 | 8.04 | 7.73 | 9.87 | 9.63 | 6.91 | 5.17 | 4.97 | 2.71 | 2.21 | 1.64 | 1.47 | 1.29 |
Research & Development | 2.94 | 2.53 | 2.43 | 1.72 | 2.33 | 1.62 | 1.87 | 2.57 | 2.23 | 2.49 | 3.1 | 2.73 | 3.01 | 3.68 | 3.43 | 4.37 | 5.4 | 4.44 | 5.13 | 4.92 |
Operating Expenses | 3.81 | 3.39 | 3.54 | 2.55 | 2.54 | 2.61 | 8.83 | 9.51 | 10.27 | 10.22 | 12.97 | 12.36 | 9.92 | 8.86 | 8.4 | 7.08 | 7.6 | 6.08 | 6.6 | 6.22 |
Operating Income | -3.57 | -3 | -3.39 | -2.21 | -2.3 | -2.39 | -3.17 | -5.39 | -5.77 | -4.82 | -11.86 | -12.36 | -9.92 | -8.86 | -8.4 | -7.08 | -7.6 | -6.08 | -6.6 | -6.22 |
Interest Expense | -0.21 | -0.25 | -0.29 | -0.3 | -0.28 | -0.42 | -4.44 | -1.63 | -2.09 | -0.93 | - | -0.84 | -1.34 | -0.93 | -0.95 | -0.27 | -0.38 | -0.19 | -0.2 | -0.26 |
Interest & Investment Income | 0.13 | 0.21 | - | 0.38 | 0.49 | 0.29 | 0.29 | 0.43 | 0.54 | 0.57 | 1.68 | 0.31 | 0.44 | 0.54 | 0.44 | 0.11 | 0.08 | 0.07 | - | 0.05 |
Currency Exchange Gain (Loss) | - | - | 0.34 | - | - | - | 0.05 | - | - | - | 0.06 | - | - | - | -0.35 | - | - | - | 0.28 | - |
Other Non Operating Income (Expenses) | -0.69 | 0.46 | 1.1 | 1.16 | -1.85 | 7.64 | 5.34 | 0.76 | 7.81 | 4.49 | 2.95 | -3.14 | -7.73 | -2.92 | 3.53 | 0.39 | 0.46 | 1.27 | 2.22 | 0.71 |
EBT Excluding Unusual Items | -4.34 | -2.59 | -2.24 | -0.98 | -3.94 | 5.13 | -1.93 | -5.82 | 0.48 | -0.7 | -7.18 | -16.02 | -18.55 | -12.16 | -5.73 | -6.85 | -7.44 | -4.93 | -4.3 | -5.72 |
Asset Writedown | - | - | - | - | - | - | -1.26 | - | - | - | -6.7 | - | - | - | - | - | - | - | - | - |
Pretax Income | -4.34 | -2.59 | -2.24 | -0.98 | -3.94 | 5.13 | -3.19 | -5.82 | 0.48 | -0.7 | -13.88 | -16.02 | -18.55 | -12.16 | -5.73 | -6.85 | -7.44 | -4.93 | -4.3 | -5.72 |
Earnings From Continuing Operations | -4.34 | -2.59 | -2.24 | -0.98 | -3.94 | 5.13 | -3.19 | -5.82 | 0.48 | -0.7 | -13.88 | -16.02 | -18.55 | -12.16 | -5.73 | -6.85 | -7.44 | -4.93 | -4.3 | -5.72 |
Minority Interest in Earnings | 1.31 | 0.99 | 0.85 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | -3.03 | -1.6 | -1.39 | -0.98 | -3.94 | 5.13 | -3.19 | -5.82 | 0.48 | -0.7 | -13.88 | -16.02 | -18.55 | -12.16 | -5.73 | -6.85 | -7.44 | -4.93 | -4.3 | -5.72 |
Net Income to Common | -3.03 | -1.6 | -1.39 | -0.98 | -3.94 | 5.13 | -3.19 | -5.82 | 0.48 | -0.7 | -13.88 | -16.02 | -18.55 | -12.16 | -5.73 | -6.85 | -7.44 | -4.93 | -4.3 | -5.72 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2,665 | 2,660 | 2,662 | 2,607 | 2,370 | 2,218 | 1,308 | 1,199 | 1,198 | 1,087 | 1,078 | 929 | 923 | 923 | 924 | 741 | 715 | 715 | 712 | 708 |
Shares Outstanding (Diluted) | 2,665 | 2,660 | 2,662 | 2,607 | 2,370 | 2,218 | 1,308 | 1,199 | 1,198 | 1,087 | 1,078 | 929 | 923 | 923 | 924 | 741 | 715 | 715 | 712 | 708 |
Shares Change (YoY) | 12.45% | 19.95% | 103.53% | 117.35% | 97.87% | 104.10% | 21.30% | 29.11% | 29.75% | 17.73% | 16.66% | 25.42% | 29.02% | 29.06% | 29.75% | 4.56% | 6.91% | 27.81% | 124.58% | 138.94% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.01 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.01 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -3.21 | -2.29 | -3.23 | -2.11 | -0.18 | -2.59 | -8.6 | -9.83 | -11.36 | -14.14 | 4.98 | -9.9 | -9.75 | -8.05 | -5.74 | -8.69 | -6.33 | -5.6 | -5.6 | -4.98 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | 0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Gross Margin | 79.93% | 80.08% | 79.38% | 80.33% | 76.32% | 86.67% | 48.17% | 83.37% | 83.37% | 78.77% | 23.08% | - | - | - | - | - | - | - | - | - |
Operating Margin | -1215.31% | -629.77% | -1745.36% | -516.86% | -757.57% | -937.65% | -26.98% | -108.98% | -107.05% | -70.34% | -247.15% | - | - | - | - | - | - | - | - | - |
Profit Margin | -1029.25% | -335.64% | -713.92% | -228.81% | -1296.05% | 2010.59% | -27.13% | -117.78% | 8.97% | -10.15% | -289.25% | - | - | - | - | - | - | - | - | - |
Free Cash Flow Margin | -1092.18% | -479.24% | -1662.37% | -493.21% | -58.22% | -1016.08% | -73.23% | -198.77% | -210.57% | -206.29% | 103.65% | - | - | - | - | - | - | - | - | - |
EBITDA | -3.5 | -2.92 | -3.33 | -2.09 | -2.13 | -2.23 | -1.39 | -4.55 | -5.3 | -3.93 | -11.22 | -12.14 | -9.72 | -8.6 | -8.21 | -6.93 | -7.46 | -5.91 | -6.42 | -6.05 |
EBITDA Margin | - | - | - | - | - | - | -11.84% | -91.99% | -98.22% | -57.26% | -233.67% | - | - | - | - | - | - | - | - | - |
D&A For EBITDA | 0.08 | 0.09 | 0.06 | 0.12 | 0.18 | 0.17 | 1.78 | 0.84 | 0.48 | 0.9 | 0.65 | 0.22 | 0.2 | 0.26 | 0.19 | 0.15 | 0.14 | 0.17 | 0.17 | 0.17 |
EBIT | -3.57 | -3 | -3.39 | -2.21 | -2.3 | -2.39 | -3.17 | -5.39 | -5.77 | -4.82 | -11.86 | -12.36 | -9.92 | -8.86 | -8.4 | -7.08 | -7.6 | -6.08 | -6.6 | -6.22 |
EBIT Margin | - | - | - | - | - | - | -26.98% | -108.98% | -107.05% | -70.34% | -247.15% | - | - | - | - | - | - | - | - | - |
Revenue as Reported | - | - | 0.19 | 0.43 | - | - | 11.75 | 4.94 | 5.39 | 6.86 | 4.8 | - | - | - | - | - | - | - | - | - |